Long-term follow-up of study participants from GlaxoSmithKline (GSK) Biologicals'-sponsored clinical trials evaluating Human Immunodeficiency Virus vaccine [F4co (p24-RT-Nef-p17)/AS01B vaccine] (732461) for therapeutic use.

Trial Profile

Long-term follow-up of study participants from GlaxoSmithKline (GSK) Biologicals'-sponsored clinical trials evaluating Human Immunodeficiency Virus vaccine [F4co (p24-RT-Nef-p17)/AS01B vaccine] (732461) for therapeutic use.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2017

At a glance

  • Drugs GSK 732461 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Jun 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 16 May 2014 Planned End Date changed from 1 Apr 2014 to 1 May 2014 as reported by ClinicalTrials.gov record.
    • 27 Feb 2014 According to ClinicalTrials.gov record, planned end date changed from 1 Dec 2017 to 1 Apr 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top